<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSX</journal-id>
<journal-id journal-id-type="hwp">sprsx</journal-id>
<journal-id journal-id-type="nlm-ta">Reprod Sci</journal-id>
<journal-title>Reproductive Sciences</journal-title>
<issn pub-type="ppub">1933-7191</issn>
<issn pub-type="epub">1933-7205</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1933719111417885</article-id>
<article-id pub-id-type="publisher-id">10.1177_1933719111417885</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Single-Nucleotide Polymorphism in the Fetal Catechol-<italic>O</italic>-methyltransferase Gene is Associated With Spontaneous Preterm Birth in African Americans</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Thota</surname>
<given-names>Chandrasekhar</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1933719111417885">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Menon</surname>
<given-names>Ramkumar</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-1933719111417885">2</xref>
<xref ref-type="aff" rid="aff3-1933719111417885">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wentz</surname>
<given-names>Melissa J.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff4-1933719111417885">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fortunato</surname>
<given-names>Stephen J.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-1933719111417885">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bartlett</surname>
<given-names>Jackie</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff5-1933719111417885">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Drobek</surname>
<given-names>Cayce O.</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="aff2-1933719111417885">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nair</surname>
<given-names>Sangeeta</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1-1933719111417885">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Al-Hendy</surname>
<given-names>Ayman</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1933719111417885">1</xref>
<xref ref-type="corresp" rid="corresp1-1933719111417885"/>
</contrib>
</contrib-group>
<aff id="aff1-1933719111417885">
<label>1</label>Department of Obstetrics and Gynecology, Center for Women’s Health Research, Meharry Medical College, Nashville, TN, USA</aff>
<aff id="aff2-1933719111417885">
<label>2</label>Perinatal Research Laboratory, Centennial Hospital, Nashville, TN, USA</aff>
<aff id="aff3-1933719111417885">
<label>3</label>Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA </aff>
<aff id="aff4-1933719111417885">
<label>4</label>MD Anderson Cancer Center, Houston, TX, USA</aff>
<aff id="aff5-1933719111417885">
<label>5</label>Vanderbilt University, Nashville, TN, USA</aff>
<author-notes>
<corresp id="corresp1-1933719111417885">Ayman Al-Hendy, Department of Obstetrics and Gynecology, Center for Women’s Health Research, Meharry Medical College, 1005 Dr D.B. Todd Jr Boulevard, Nashville, TN 37208, USA Email: <email>ahendy@mmc.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>19</volume>
<issue>2</issue>
<fpage>135</fpage>
<lpage>142</lpage>
<permissions>
<copyright-statement>© Society for Gynecologic Investigation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society for Gynecologic Investigation</copyright-holder>
</permissions>
<abstract>
<p>Catechol-O-methyltransferase (COMT) activity has been reported to be higher in African Americans (AA) than Caucasians (Cau). COMT converts 2- and 4-hydroxy (OH) estrogens to 2- and 4-methoxyestrogens, respectively, and can increase estrogenic milieu locally in tissues. To assess whether the increased incidence of preterm birth (PTB) among AA women is associated with single-nucleotide polymorphism (SNP) in the COMT gene, we examined variations in maternal and fetal COMT genes and their association with pregnancy outcomes (term vs preterm pregnancies) using 4 functional SNPs: rs4633, rs4680, rs4818, and rs6269 in both AA and Cau. We analyzed samples from 267 AA women (191 term and 76 preterm pregnancies) and 339 Cau (194 term and 145 preterm pregnancies) in this study. The results showed a significant difference (P &lt; .05) in allele and genotype frequencies between term and preterm AA and Cau women in 3 SNPs in both maternal and fetal DNA. The analysis revealed that in AA fetal COMT genes, SNP rs4818 is associated with PTB at the allele (C; P &lt; .001), genotype (C/C; P &lt; .01), and 2- (P &lt; .03) and 3 (P &lt; .04)-window haplotype levels. Multidimensionality reduction analysis also showed a significant (P &lt; .01) association between rs4818 and PTB. In conclusion, our study demonstrated that a synonymous polymorphism, rs4818 in the fetal COMT gene, is associated with PTB in AA.</p>
</abstract>
<kwd-group>
<kwd>preterm birth</kwd>
<kwd>African Americans</kwd>
<kwd>Caucasians</kwd>
<kwd>single-nucleotide polymorphism</kwd>
<kwd>catechol-O-methyltransferase</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1933719111417885">
<title>Introduction</title>
<p>Preterm birth ([PTB] &lt;37 weeks of gestation) accounts for 70% of perinatal mortality and 50% of morbidity and is a major clinical dilemma in modern obstetrics.<sup><xref ref-type="bibr" rid="bibr1-1933719111417885">1</xref></sup> In the United States, approximately 12.7% of all births are preterm,<sup><xref ref-type="bibr" rid="bibr2-1933719111417885">2</xref></sup> costing more than $26 billion/year. The incidence of PTB among African American (AA) women is significantly higher than that of other ethnic groups.<sup><xref ref-type="bibr" rid="bibr3-1933719111417885">3</xref></sup> The literature indicates that most socioeconomic parameters and pathophysiological pathways do not explain the ethnic disparity in PTB.<sup><xref ref-type="bibr" rid="bibr4-1933719111417885">4</xref></sup> Novel data from our laboratory have shown that catechol-O-methyltransferase (COMT), which mediates the methylation of hypoestrogenic 2-hydroxyestrogen to hyperestrogenic 2-methoxyestrogen, is high among AA compared with Caucasians (Cau).<sup><xref ref-type="bibr" rid="bibr5-1933719111417885">5</xref></sup> Because estrogens play an important role in labor and delivery, we hypothesize that the genetic variants of the COMT gene that regulate estrogenic activity have a role in the increased incidence of PTB in AA. </p>
<p>COMT is an intracellular enzyme that plays an important role in metabolizing catecholestrogens. COMT expression has been reported in many tissues, including fetal membranes.<sup><xref ref-type="bibr" rid="bibr6-1933719111417885">6</xref><xref ref-type="bibr" rid="bibr7-1933719111417885"/>–<xref ref-type="bibr" rid="bibr8-1933719111417885">8</xref>
</sup> Gene expression<sup><xref ref-type="bibr" rid="bibr9-1933719111417885">9</xref></sup> of COMT is controlled by 2 distinct promoters located in Exon 3 of Chromosome 22. The distal 5′ promoter (P2) regulates the synthesis of both membrane-bound (MB-COMT) and soluble COMT (S-COMT) proteins, <sup>
<xref ref-type="bibr" rid="bibr10-1933719111417885">10</xref>
<xref ref-type="bibr" rid="bibr11-1933719111417885"/>–<xref ref-type="bibr" rid="bibr12-1933719111417885">12</xref>
</sup> while the P1 promoter regulates the synthesis of S-COMT. In vertebrates, COMT appears mostly in the soluble form, and only a minor fraction is in the particulate form (as MB-COMT).<sup>
<xref ref-type="bibr" rid="bibr13-1933719111417885">13</xref>
</sup> COMT converts 2- and 4-hydroxy (OH) estrogens to 2- and 4-methoxy estrogens, respectively. 2-Hydroxyestrogens have a low affinity to the estrogen receptor and therefore have little or no estrogenic effect.<sup>
<xref ref-type="bibr" rid="bibr14-1933719111417885">14</xref>
<xref ref-type="bibr" rid="bibr15-1933719111417885"/>–<xref ref-type="bibr" rid="bibr16-1933719111417885">16</xref>
</sup> 2-Methoxyestrone is one of the most abundant estrogen metabolites in human plasma<sup>
<xref ref-type="bibr" rid="bibr17-1933719111417885">17</xref>
</sup> and has a very high affinity for the sex hormone-binding protein.<sup>
<xref ref-type="bibr" rid="bibr18-1933719111417885">18</xref>
</sup> 2-Methoxyestradiol has been reported to inhibit breast cancer by inhibiting tubulin polymerization.<sup>
<xref ref-type="bibr" rid="bibr19-1933719111417885">19</xref>
</sup> It was reported that COMT knockout mice exhibited preeclampsia-like symptoms,<sup>
<xref ref-type="bibr" rid="bibr20-1933719111417885">20</xref>
</sup> suggesting that COMT plays an important role during pregnancy. However, the role of COMT in human pregnancy and delivery is not clear.</p>
<p>Variants in the COMT genotype (Val/Val, Val/Met, and Met/Met) have been reported to be associated with various physiological abnormalities. It was recently reported that the mean birth weight of infants may be related to their high active COMT Val/Val genotype.<sup>
<xref ref-type="bibr" rid="bibr21-1933719111417885">21</xref>
</sup> Studies conducted in our laboratory to determine the frequency of COMT polymorphisms among ethnically diverse women revealed a significantly higher prevalence of the COMT Val/Val genotype in AA (47%) versus Cau (19%) or Hispanic women (30%).<sup>
<xref ref-type="bibr" rid="bibr5-1933719111417885">5</xref>
</sup> In addition, we observed a significant association between the high active Val/Val variation of the COMT gene and a higher prevalence of uterine leiomyoma (fibroids), an estrogen-dependent disorder, in AA women. Therefore, we speculate that functional single-nucleotide polymorphisms (SNPs) contribute to higher COMT activity and higher estrogen milieu in AA, resulting in their higher PTB rate. The objective of this study is to test the association between known functional COMT SNPs and PTB in AA and Cau, using both maternal and fetal DNA samples.</p>
</sec>
<sec id="section2-1933719111417885">
<title>Materials and Methods</title>
<sec id="section3-1933719111417885">
<title>Participants</title>
<p>The AA and Cau women of non-Hispanic origin included in the study were recruited at Centennial Women’s Hospital in Nashville, TN, between September 2003 and December 2005. Race was identified by a self-report questionnaire that traced the ancestry of respondents back to 3 generations, starting from the fetus.<sup>
<xref ref-type="bibr" rid="bibr22-1933719111417885">22</xref>
</sup> Individuals who had more than 1 ethnic ancestry were excluded from the study. Participants included in the study were between the ages of 18 and 40 years and had singleton live births. Gestational age was determined by last menstrual period and corroborated by ultrasound dating. The participants were recruited at the time of active labor, defined as the presence of regular uterine contractions (2 contractions/10 minutes) with documented cervical changes, followed by delivery. Cases consisted of women who delivered preterm (prior to 37<sup>0/7</sup> weeks gestation). Participants with multiple gestations, preeclampsia, preterm premature rupture of membranes, placenta previa, fetal anomalies, gestational diabetes, poly- and oligohydramnios, and other complications, such as surgeries during pregnancy, were excluded. The controls were women who had term deliveries (≥37<sup>0/7</sup> weeks of gestation) with no medical or obstetrical complications during pregnancy. We used noncontiguous gestational ages to define the cases and controls to minimize phenotypic overlap. The study was approved by the TriStar Nashville Institutional Review Board (IRB) at Centennial Medical Center and the Meharry Medical College IRB, Nashville, TN. All participants provided informed consent.</p>
</sec>
<sec id="section4-1933719111417885">
<title>Sample Collection</title>
<p>The samples for the study consisted of 267 AA women (191 controls and 76 cases) and 339 Cau women (194 controls and 145 cases). DNA was extracted from maternal (606) and cord blood (568) samples collected from both controls and cases using the Autopure automated system (Gentra Systems, Minneapolis, Minnesota). DNA samples included Cau (maternal: 145 cases and 194 controls; fetal: 140 cases and 179 controls) and AA (maternal: 76 cases and 191 controls; fetal: 66 cases and 183 controls). </p>
</sec>
<sec id="section5-1933719111417885">
<title>Genotyping and Genetic Analysis</title>
<p>The SNPs selected for our investigation included the commonly used Val/Met sequence variant (SNP; rs4680) and an SNP (rs4633) within exon 3 of the MB-COMT transcript or exon 1 of the S-COMT transcript that defines a synonymous C-T (His/His) change. To have better coverage of the 27-kb genomic region, SNP rs4818, a synonymous C-G (Leu/Leu), and rs6269 from promoter region were also analyzed based on their ability to tag surrounding variants from the HapMap (http://www.hapmap.org). The criterion for Cau tag SNPs was a minor allele frequency (MAF) of 0.07; the criterion for AA was an MAF of 0.20. For both, we used a linkage disequilibrium (LD) cutoff of <italic>r</italic><sup>2</sup> = .8. The <italic>r</italic>s numbers of SNPs from the National Institutes of Health (NIH) database, chromosome, and base pair position on chromosome, are shown in <xref ref-type="table" rid="table1-1933719111417885">Table 1</xref>. Genotyping was completed using the Illumina GoldenGate genotyping system (Illumina, San Diego, California).</p>
<table-wrap id="table1-1933719111417885" position="float">
<label>Table 1.</label>
<caption>
<p>Single-Nucleotide Polymorphisms (SNPs): ID Numbers (RS Number<sup><xref ref-type="table-fn" rid="table-fn7-1933719111417885">a</xref></sup>) and Their Location in <italic>COMT</italic> Gene.</p>
</caption>
<graphic alternate-form-of="table1-1933719111417885" xlink:href="10.1177_1933719111417885-table1.tif"/>
<table>
<thead>
<tr>
<th>SNP</th>
<th>Gene</th>
<th>Chromosome</th>
<th>Location<sup><xref ref-type="table-fn" rid="table-fn8-1933719111417885">b</xref></sup>
</th>
<th>Variation</th>
<th>Amino Acid</th>
</tr>
</thead>
<tbody>
<tr>
<td>RS6269</td>
<td>COMT</td>
<td>22</td>
<td>18,329,952</td>
<td>A/G</td>
<td>Promoter region</td>
</tr>
<tr>
<td>RS4633</td>
<td>COMT</td>
<td>22</td>
<td>18,330,235</td>
<td>C/T</td>
<td>His62/His</td>
</tr>
<tr>
<td>RS4818</td>
<td>COMT</td>
<td>22</td>
<td>18,331,207</td>
<td>C/G</td>
<td>Leu136/Leu</td>
</tr>
<tr>
<td>RS4680</td>
<td>COMT</td>
<td>22</td>
<td>18,331,271</td>
<td>A/G</td>
<td>Val158/Met</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-1933719111417885">
<p>Abbreviation: COMT, catechol-O-methyltransferase.</p>
</fn>
<fn id="table-fn7-1933719111417885">
<p>
<sup>a</sup> Nackley et al.<sup><xref ref-type="bibr" rid="bibr32-1933719111417885">32</xref></sup>
</p>
</fn>
<fn id="table-fn8-1933719111417885">
<p>
<sup>b</sup> Location is from ENSEMBL using Build 36.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section6-1933719111417885">
<title>Statistical Analysis</title>
<p>The Shapiro–Wilk test of normality was performed for gestational age, gestational and birth weight, Appearance, Pulse, Grimace, Activity, Respiration (APGAR) score at 1 and 5 minutes, and maternal age. All measurements deviated significantly from normality, with the exception of maternal age; as a result, the Mann–Whitney 2-sample rank sum test was used to test for statistical differences between medians of cases and controls. Student <italic>t </italic>tests were used to test for statistical differences between case and control means for maternal age.</p>
</sec>
<sec id="section7-1933719111417885">
<title>Genetic Analysis</title>
<p>Single-locus allele frequency differences within the Cau and AA cases and controls were analyzed using the software Tools for Population Genetic Analysis (TFPGA), Version 1.3, available at http://www.marksgeneticsoftware.net/index.html.<sup>
<xref ref-type="bibr" rid="bibr23-1933719111417885">23</xref>
</sup> Differences between the cases and controls in genotype distributions at single loci were assessed with the Metropolis algorithm to obtain <italic>P</italic> values, as implemented in the program R X C.<sup>
<xref ref-type="bibr" rid="bibr24-1933719111417885">24</xref>
</sup> Single-locus Hardy–Weinberg equilibrium (HWE) analyses were also performed using TFPGA software. Statistical significance for the above was determined using Fisher exact tests.</p>
<p>Haplotype frequencies from the genotype data and differences in case–control haplotype distributions were tested using the FastEH+ program, which uses the expectation maximization (EM) algorithm.<sup>25</sup> Significant deviations were detected in random haplotypes using empirically derived <italic>P</italic> values with this software. Haplotype blocks were assigned using <italic>D</italic>′ confidence interval algorithm.<sup>
<xref ref-type="bibr" rid="bibr26-1933719111417885">26</xref>
</sup> The number below the lines between blocks is the multiallelic <italic>D</italic>′ between blocks (<xref ref-type="fig" rid="fig1-1933719111417885">Figure 1</xref>)<bold>.</bold> This gives a measure of LD and indicates the <italic>D</italic>′ statistic for 2 consecutive SNPs. <italic>D</italic>′ = 1 indicates complete LD and decreases as the value of <italic>D</italic>′ decreases. Regions with high LD (<italic>D</italic>′ = 1 and log of the odds [LOD] &gt; 2) as well as SNPs in the strong LD blocks are shown in red, with the intensity decreasing with decreased <italic>D</italic> value. Regions with weak LD (0.21 &lt; <italic>D</italic>′ &lt; 1 and LOD &gt; 2) are shown in blue, and regions with no LD and LOD scores (LOD &lt; 2) are shown in white. Pairwise measures of <italic>D</italic>′ and <italic>r</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1933719111417885">2</xref>
</sup> were performed with HaploView software to assess LD. </p>
<fig id="fig1-1933719111417885" position="float">
<label>Figure 1.</label>
<caption>
<p>HaploView-generated LD map of 4 SNPs within the COMT gene. Haplotype blocks are assigned using the D′ confidence interval algorithm created by Gabriel et al<sup>26</sup>. D' = 1 indicates complete LD and decreases as the value of D′ decreases. Regions with high LD (D′ = 1 and LOD &gt; 2) as well as SNPs in the strong LD blocks are shown in red. Decrease in intensity suggests decreased D value and LD. Regions with weak LD (0.21 &lt; D′ &lt; 1 and LOD &gt; 2) are shown in blue. Regions with no LD (D′ &lt; 1 and LOD &lt; 2) are shown in white. A, Linkage disequilibrium (LD) maps in maternal samples: (a) Cau: control*; (b) Cau: cases**; (c) AA: control; (d) AA: cases. B, Linkage disequilibrium (LD) map in fetal samples: (a) Cau: control; (b) Cau: cases; (c) AA: control; (d) AA: cases. SNP, single-nucleotide polymorphism; COMT, catechol-O-methyltransferase; LOD, log of the odds; Cau, Caucasians; AA, African Americans; *term delivery; **preterm delivery.</p>
</caption>
<graphic alternate-form-of="fig1-1933719111417885" xlink:href="10.1177_1933719111417885-fig1.tif"/>
</fig>
</sec>
<sec id="section8-1933719111417885">
<title>Multilocus Analysis</title>
<p>Multilocus analysis was performed using the multifactor dimensionality reduction (MDR) method.<sup>
<xref ref-type="bibr" rid="bibr27-1933719111417885">27</xref>,<xref ref-type="bibr" rid="bibr28-1933719111417885">28</xref>
</sup> Multifactor dimensionality reduction collapses all the genetic data into 2 categories, high and low risk, by comparing all single-locus and all multilocus combinations and then categorizing each genotype into either high risk or low risk based on the ratio of cases to controls that have that genotype. Multifactor dimensionality reduction ultimately selects 1 genetic model, either single- or multilocus, which most successfully predicts phenotype or disease status. The prediction error of the model is estimated using 10-fold cross-validation (CV). Simply put, the data are divided into 10 equal parts, and 9 of the 10 data are used to generate the model. The model is then tested on the remaining 1 of the 10 data. This method is performed for each of the 9 of 10 and 1 of 10 combinations. The 10-fold CV is repeated 10 times to ensure that the results are not due to chance divisions of the data. The average number of times that the same best model comes up is given as the CV consistency and is represented as a continuous value from 1 to 10. Both the CV consistency and the prediction error minimization are used to choose the single best model. Statistical significance is determined empirically by permuting the case and control labels 1000 times. We eliminated the problem of multiple testing by generating the <italic>P</italic> values with permutations.</p>
<p>Multifactor dimensionality reduction is best suited for equal number of cases and controls. Because of the excess of controls in our sample, both undersampling of the control group and oversampling of the case group were implemented with the MDR open source software, available at www.epistasis.org. These methods have been shown to be effective in determining the best genetic model using MDR.<sup>
<xref ref-type="bibr" rid="bibr29-1933719111417885">29</xref>,<xref ref-type="bibr" rid="bibr30-1933719111417885">30</xref>
</sup> Results for the 2 resampling methods were compared for consistency. Odds ratios, sensitivity, and specificity were calculated using the multilocus model determined from the MDR analysis, as implemented in the software. </p>
</sec>
</sec>
<sec id="section9-1933719111417885">
<title>Results</title>
<p>As expected, the cases and controls differed in gestational age, birth weight, and APGAR scores in both ethnic groups (<xref ref-type="table" rid="table2-1933719111417885">Table 2</xref>). There were no significant differences in maternal age and socioeconomic factors (education, annual income, and smoking) between the cases and controls (data not shown).</p>
<table-wrap id="table2-1933719111417885" position="float">
<label>Table 2.</label>
<caption>
<p>Maternal Characteristics and Pregnancy Outcomes in Women That Delivered Preterm (Cases) and Term (Controls)</p>
</caption>
<graphic alternate-form-of="table2-1933719111417885" xlink:href="10.1177_1933719111417885-table2.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">Characteristics</th>
<th colspan="3">Caucasians</th>
<th colspan="3">African Americans</th>
</tr>
<tr>
<th>Controls</th>
<th>Cases</th>
<th>2-Tailed <italic>P</italic> Value</th>
<th>Controls</th>
<th>Cases</th>
<th>2-Tailed <italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gestational age, weeks, mean (SD)</td>
<td>38.9 (1.0)</td>
<td>32.9 (3.1)</td>
<td>&lt;.001</td>
<td>39.0 (1.0)</td>
<td>32.3 (3.9)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Gestational weight, g </td>
<td>3446 (2100–4661)</td>
<td>2150 (370–3790)</td>
<td>&lt;.001</td>
<td>3190 (1952–4517)</td>
<td>2240 (462–3782)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Birth weight, g, mean (SD)</td>
<td>3407 (427)</td>
<td>2026 (719)</td>
<td>&lt;.001</td>
<td>3226 (436)</td>
<td>2094 (642)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>APGAR 1</td>
<td>8 (4–9)</td>
<td>8 (1–9)</td>
<td>&lt;.001</td>
<td>8 (3–9)</td>
<td>8 (1–9)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>APGAR 5</td>
<td>9 (7–10)</td>
<td>9 (1–9)</td>
<td>&lt;.001</td>
<td>9 (7–10)</td>
<td>9 (6–10)</td>
<td>&lt;.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn9-1933719111417885">
<p>Abbreviation: SD, standard deviation; APGAR 1 and 5, Appearance, Pulse, Grimace, Activity, Respiration at first and five minutes respectively.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section10-1933719111417885">
<title>Hardy Weinberg equilibrium (HWE) Analysis</title>
<p>All SNPs in the maternal and fetal samples obtained from both the Cau and AA cases and controls were used in HWE (<xref ref-type="table" rid="table3-1933719111417885">Table 3</xref>). The data were analyzed using PowerMarker software,<sup>
<xref ref-type="bibr" rid="bibr31-1933719111417885">31</xref>
</sup> and statistical significance for these analyses was determined using Fisher exact test.</p>
<table-wrap id="table3-1933719111417885" position="float">
<label>Table 3.</label>
<caption>
<p>Comparison For Hardy–Weinberg Equilibrium in COMT Gene in Caucasian and African American Women That Delivered Preterm (Cases) and Term (Controls)<sup><xref ref-type="table-fn" rid="table-fn11-1933719111417885">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table3-1933719111417885" xlink:href="10.1177_1933719111417885-table3.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>
</th>
<th colspan="4">Caucasians</th>
<th colspan="4">African Americans</th>
</tr>
<tr>
<th>SNP</th>
<th>MA</th>
<th colspan="2">Cases</th>
<th colspan="2">Controls</th>
<th colspan="2">Cases</th>
<th colspan="2">Controls</th>
</tr>
<tr>
<th>
</th>
<th>
</th>
<th>n</th>
<th>MAF</th>
<th>n</th>
<th>MAF</th>
<th>n</th>
<th>MAF</th>
<th>n</th>
<th>MAF</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="10">Maternal <italic>COMT</italic> gene</td>
</tr>
<tr>
<td> RS6269</td>
<td>G</td>
<td>68</td>
<td>0.456</td>
<td>188</td>
<td>0.414</td>
<td>41</td>
<td>0.317</td>
<td>223</td>
<td>0.346</td>
</tr>
<tr>
<td> RS4633</td>
<td>T</td>
<td>68</td>
<td>0.455</td>
<td>188</td>
<td>0.489</td>
<td>41</td>
<td>0.375</td>
<td>223</td>
<td>0.346</td>
</tr>
<tr>
<td> RS4818</td>
<td>G</td>
<td>68</td>
<td>0.463</td>
<td>188</td>
<td>0.411</td>
<td>41</td>
<td>0.171</td>
<td>223</td>
<td>0.220</td>
</tr>
<tr>
<td> RS4680</td>
<td>A</td>
<td>68</td>
<td>0.455</td>
<td>188</td>
<td>0.487</td>
<td>41</td>
<td>0.293</td>
<td>223</td>
<td>0.287</td>
</tr>
<tr>
<td colspan="10">Fetal <italic>COMT</italic> gene</td>
</tr>
<tr>
<td> RS6269</td>
<td>G</td>
<td>70</td>
<td>0.343</td>
<td>196</td>
<td>0.408</td>
<td>35</td>
<td>0.286</td>
<td>219</td>
<td>0.393</td>
</tr>
<tr>
<td> RS4633</td>
<td>C</td>
<td>70</td>
<td>0.443</td>
<td>197</td>
<td>0.500</td>
<td>35</td>
<td>0.371</td>
<td>217</td>
<td>0.300</td>
</tr>
<tr>
<td> RS4818</td>
<td>G</td>
<td>70</td>
<td>0.314</td>
<td>193</td>
<td>0.391</td>
<td>35</td>
<td>0.086</td>
<td>221</td>
<td>0.251</td>
</tr>
<tr>
<td> RS4680</td>
<td>G</td>
<td>70</td>
<td>0.450</td>
<td>195</td>
<td>0.490</td>
<td>35</td>
<td>0.357</td>
<td>217</td>
<td>0.288</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn10-1933719111417885">
<p>Abbreviations: COMT, catechol-O-methyltransferase; SNP, single-nucleotide polymorphism; MA, minor allele; MAF, minor allele frequency.</p>
</fn>
<fn id="table-fn11-1933719111417885">
<p>
<sup>a</sup>Significance by Fisher exact test.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section11-1933719111417885">
<title>Allele and Genotype Frequencies</title>
<p>A total of 16 comparisons were made (4 SNPs and 4 different groups: maternal controls and cases as well as fetal controls and cases) between races for both allele and genotype frequencies (<xref ref-type="table" rid="table4-1933719111417885">Table 4</xref>). Significant single SNP differences were observed for allele frequencies in maternal controls between races at rs6269 (A; <italic>P</italic> &lt; .05) and rs4633 (C; <italic>P</italic> = .001), and rs4818 (C; <italic>P</italic> &lt; .001) and rs4680 (A; <italic>P</italic> = .001). Similarly, allele frequencies in the maternal cases were significantly different at SNPs rs4818 (<italic>P </italic>&lt; .001), rs6269 (<italic>P</italic> = .03), rs4633 (<italic>P</italic> = .001), and rs4680 (<italic>P</italic> = .001). Allele frequencies at SNP rs6269 in the fetal controls and cases did not show any difference; however, the frequencies at the remaining 3 SNPs were significantly different (<italic>P</italic> ≤ .001).</p>
<table-wrap id="table4-1933719111417885" position="float">
<label>Table 4.</label>
<caption>
<p>Allele and Genotype Frequency Differences Between Caucasian and African Americans<sup><xref ref-type="table-fn" rid="table-fn13-1933719111417885">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table4-1933719111417885" xlink:href="10.1177_1933719111417885-table4.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>
</th>
<th colspan="4">
<italic>P</italic> Value</th>
</tr>
<tr>
<th rowspan="2">SNP</th>
<th rowspan="2">Allele/Genotype</th>
<th colspan="2">Maternal</th>
<th colspan="2">Fetal</th>
</tr>
<tr>
<th>Cases</th>
<th>Control</th>
<th>Cases</th>
<th>Control</th>
</tr>
</thead>
<tbody>
<tr>
<td>Allele</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> RS6269</td>
<td>A</td>
<td>.03</td>
<td>.04</td>
<td>.34</td>
<td>.65</td>
</tr>
<tr>
<td> RS4633</td>
<td>C</td>
<td>.25</td>
<td>.001</td>
<td>.01</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> RS4818</td>
<td>C</td>
<td>&lt;.001</td>
<td>&lt;.001</td>
<td>&lt;.001</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> RS4680</td>
<td>A</td>
<td>.02</td>
<td>.001</td>
<td>.005</td>
<td>&lt;.001</td>
</tr>
<tr>
<td colspan="6">Genotype</td>
</tr>
<tr>
<td> RS6269</td>
<td>A/A</td>
<td>.06</td>
<td>.14</td>
<td>.57</td>
<td>.11</td>
</tr>
<tr>
<td> RS4633</td>
<td>C/C</td>
<td>.06</td>
<td>&lt;.001</td>
<td>.03</td>
<td>.001</td>
</tr>
<tr>
<td> RS4818</td>
<td>C/C</td>
<td>&lt; .001</td>
<td>.001</td>
<td>.012</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> RS4680</td>
<td>A/A</td>
<td>.04</td>
<td>.001</td>
<td>.052</td>
<td>.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn12-1933719111417885">
<p>Abbreviation: SNP, single-nucleotide polymorphism.</p>
</fn>
<fn id="table-fn13-1933719111417885">
<p>
<sup>a</sup> <italic>P</italic> values are derived using PowerMarker software (http://statgen.ncsu.edu/powermarker/).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Genotype frequencies in the maternal controls showed significant (<italic>P</italic> ≤ .001) differences at rs4818(C/C), rs4633 (C/C), and rs4680 (A/A) but not at rs6269 (A/A). In the maternal cases, genotype frequencies showed differences at rs4818 (C/C; <italic>P</italic> &lt; .001) and rs4680 (A/A; <italic>P </italic>&lt; .04) but not at rs4633(C/C) or rs6269 (A/A). In the fetal samples, genotype frequencies showed significant differences in both the controls and cases at rs4818, rs4633, and rs4680 but not at site rs6269 (<xref ref-type="table" rid="table4-1933719111417885">Table 4</xref>). </p>
</sec>
<sec id="section12-1933719111417885">
<title>Association Analysis of Individual SNPs</title>
<sec id="section13-1933719111417885">
<title>Allele association</title>
<p>Single-locus analysis of SNP rs4818 in AA fetal COMT DNA revealed a significant association (<italic>P</italic> = .001) between allele C and PTB, with odds ratio (OR) 3.58 (95% confidence interval [CI]: 1.51-8.49; <xref ref-type="table" rid="table5-1933719111417885">Table 5</xref>). However, no such association was seen between rs4818 and PTB in fetal COMT DNA obtained from Cau. None of the alleles in the other 3 SNPs (rs6269, rs4633, and rs4680) showed any association with PTB either in Cau or in AA fetal DNA. None of the SNPs analyzed in the maternal DNA of either the Cau or AA women showed any association with PTB (<xref ref-type="table" rid="table5-1933719111417885">Table 5</xref>). </p>
<table-wrap id="table5-1933719111417885" position="float">
<label>Table 5.</label>
<caption>
<p>Allele Association of SNPs Within COMT Gene With Preterm Birth in Caucasians and African Americans</p>
</caption>
<graphic alternate-form-of="table5-1933719111417885" xlink:href="10.1177_1933719111417885-table5.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">SNP</th>
<th rowspan="2">Allele</th>
<th>Maternal</th>
<th rowspan="2">
<italic>P</italic> Value</th>
<th>Fetal</th>
<th rowspan="2">
<italic>P</italic> Value<sup><xref ref-type="table-fn" rid="table-fn15-1933719111417885">a</xref></sup>
</th>
</tr>
<tr>
<th>Odds Ratio (95% CI)</th>
<th>Odds Ratio (95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Caucasians</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td rowspan="2"> RS6269</td>
<td>A</td>
<td rowspan="2">0.84 (0.57,1.25)</td>
<td rowspan="2">.36</td>
<td rowspan="2">0.76 (0.51,1.13)</td>
<td rowspan="2">.17</td>
</tr>
<tr>
<td>G</td>
</tr>
<tr>
<td rowspan="2"> RS4633</td>
<td>C</td>
<td rowspan="2">1.15 (0.77,1.70)</td>
<td rowspan="2">.45</td>
<td rowspan="2">0.79 (0.54,1.17)</td>
<td rowspan="2">.28</td>
</tr>
<tr>
<td>T</td>
</tr>
<tr>
<td rowspan="2"> RS4818</td>
<td>C</td>
<td rowspan="2">0.81 (0.54,1.21)</td>
<td rowspan="2">.29</td>
<td rowspan="2">1.40 (0.93,2.12)</td>
<td rowspan="2">.11</td>
</tr>
<tr>
<td>G</td>
</tr>
<tr>
<td rowspan="2"> RS4680</td>
<td>A</td>
<td rowspan="2">0.88 (0.59,1.31)</td>
<td rowspan="2">.53</td>
<td rowspan="2">1.27 (0.86,1.88)</td>
<td rowspan="2">.18</td>
</tr>
<tr>
<td>G</td>
</tr>
<tr>
<td colspan="6">African Americans</td>
</tr>
<tr>
<td rowspan="2"> RS6269</td>
<td>A</td>
<td rowspan="2">1.14 (0.69,1.89)</td>
<td rowspan="2">.69</td>
<td rowspan="2">1.62 (0.93,2.81)</td>
<td rowspan="2">.10 </td>
</tr>
<tr>
<td>G</td>
</tr>
<tr>
<td rowspan="2"> RS4633</td>
<td>C</td>
<td rowspan="2">0.88 (0.54,1.45)</td>
<td rowspan="2">.52</td>
<td rowspan="2">0.72 (0.43,1.23)</td>
<td rowspan="2">.27</td>
</tr>
<tr>
<td>T</td>
</tr>
<tr>
<td rowspan="2"> RS4818</td>
<td>C</td>
<td rowspan="2">1.37 (0.74,2.53)</td>
<td rowspan="2">.38</td>
<td rowspan="2">3.58 (1.51,8.49)</td>
<td rowspan="2">&lt;.001<sup><xref ref-type="table-fn" rid="table-fn16-1933719111417885">b</xref></sup>
</td>
</tr>
<tr>
<td>G</td>
</tr>
<tr>
<td rowspan="2"> RS4680</td>
<td>A</td>
<td rowspan="2">1.03 (0.61,1.73)</td>
<td rowspan="2">.89</td>
<td rowspan="2">1.37 (0.80,2.34) </td>
<td rowspan="2">.21</td>
</tr>
<tr>
<td>G</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn14-1933719111417885">
<p>Abbreviations: COMT, catechol-O-methyltransferase; SNP, single-nulceotide polymorphism; CI, confidence interval.</p>
</fn>
<fn id="table-fn15-1933719111417885">
<p>
<sup>a</sup>
<italic> P</italic> value obtained by Fisher exact test.</p>
</fn>
<fn id="table-fn16-1933719111417885">
<p>
<sup>b</sup> Single-nucleotide polymorphism NP rs4818 shows a significant association with preterm birth in African Americans.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section14-1933719111417885">
<title>Genotype association</title>
<p>Genotype analysis showed a strong association (<italic>P</italic> = .01) between the C/C genotype of SNP rs4818 and PTB (<xref ref-type="table" rid="table6-1933719111417885">Table 6</xref>) in AA fetal COMT DNA. There was no association between the other SNPs and PTB in fetal DNA. None of the COMT SNPs studied showed associations with PTB in AA maternal DNA. In Cau, we did not see association between any of these SNPs and PTB either in maternal or in fetal DNA.</p>
<table-wrap id="table6-1933719111417885" position="float">
<label>Table 6.</label>
<caption>
<p>Genotype Association of SNPs Within COMT Gene With Preterm Birth in Caucasians and African Americans<sup><xref ref-type="table-fn" rid="table-fn18-1933719111417885">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table6-1933719111417885" xlink:href="10.1177_1933719111417885-table6.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">SNP</th>
<th rowspan="2">Genotype</th>
<th colspan="3">Maternal</th>
<th colspan="3">Frequency</th>
</tr>
<tr>
<th>Cases</th>
<th>Controls </th>
<th>
<italic>P</italic> Value</th>
<th>Cases</th>
<th>Controls</th>
<th>
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Caucasians</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> RS6269</td>
<td>A/A</td>
<td>0.26</td>
<td>0.36</td>
<td>.29</td>
<td>0.44</td>
<td>0.33</td>
<td>.22</td>
</tr>
<tr>
<td> RS4633</td>
<td>C/C</td>
<td>0.28</td>
<td>0.27</td>
<td>.57</td>
<td>0.21</td>
<td>0.23</td>
<td>.27</td>
</tr>
<tr>
<td> RS4818</td>
<td>C/C</td>
<td>0.25</td>
<td>0.35</td>
<td>.32</td>
<td>0.49</td>
<td>0.34</td>
<td>.08</td>
</tr>
<tr>
<td> RS4680</td>
<td>A/A</td>
<td>0.19</td>
<td>0.25</td>
<td>.65</td>
<td>0.33</td>
<td>0.23</td>
<td>.29</td>
</tr>
<tr>
<td>African Americans</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> RS6269</td>
<td>A/A</td>
<td>0.48</td>
<td>0.42</td>
<td>.72</td>
<td>0.48 </td>
<td>0.39 </td>
<td>.16</td>
</tr>
<tr>
<td> RS4633</td>
<td>C/C</td>
<td>0.47</td>
<td>0.46</td>
<td>.50</td>
<td>0.37 </td>
<td>0.49 </td>
<td>.39</td>
</tr>
<tr>
<td> RS4818</td>
<td>C/C</td>
<td>0.73</td>
<td>0.60</td>
<td>.08</td>
<td>0.83 </td>
<td>0.57 </td>
<td>.01<sup><xref ref-type="table-fn" rid="table-fn18-1933719111417885">a</xref></sup>
</td>
</tr>
<tr>
<td> RS4680</td>
<td>A/A</td>
<td>0.12</td>
<td>0.08</td>
<td>.65</td>
<td>0.14 </td>
<td>0.08 </td>
<td>.40</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn17-1933719111417885">
<p>Abbreviations: COMT, catechol-O-methyltransferase; SNP, single-nucleotide polymorphism.</p>
</fn>
<fn id="table-fn18-1933719111417885">
<p>
<sup>a</sup> <italic>P</italic> values from Fisher exact test.</p>
</fn>
<fn id="table-fn19-1933719111417885">
<p>
<sup>b</sup> Significant association with preterm birth in African Americans.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section15-1933719111417885">
<title>Haplotype Analysis</title>
<p>Haplotype-based association analysis was performed for all 3 possible SNP combinations within COMT, using PowerMarker statistical software. Separate haplotype analyses were performed on the maternal and the fetal DNA samples obtained from Cau and AA to study the descent pattern of a combination of these alleles at different sites on a single chromosome. In 2-marker sliding window haplotype analysis, rs4633-rs4818 and rs4818-rs4680 in the fetal DNA of AA showed a significant association with PTB (<italic>P</italic> = .03; <xref ref-type="table" rid="table7-1933719111417885">Table 7</xref>). No significant haplotype associations were found in AA maternal samples or Cau (maternal and fetal) samples (<xref ref-type="table" rid="table7-1933719111417885">Table 7</xref>). In 3-marker sliding window haplotype analysis, haplotype rs4680-rs4818-rs4633 in fetal DNA showed a significant (<italic>P </italic>= .04) association with PTB (<xref ref-type="table" rid="table7-1933719111417885">Table 7</xref>). However, in 4-marker sliding window haplotype analysis, no association was observed with PTB (<xref ref-type="table" rid="table7-1933719111417885">Table 7</xref>).</p>
<table-wrap id="table7-1933719111417885" position="float">
<label>Table 7.</label>
<caption>
<p>Association of COMT Haplotype With Preterm Birth in African Americans</p>
</caption>
<graphic alternate-form-of="table7-1933719111417885" xlink:href="10.1177_1933719111417885-table7.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">SNPs</th>
<th colspan="3">Maternal</th>
<th colspan="3">Fetal</th>
</tr>
<tr>
<th>Haplotype</th>
<th>Frequency</th>
<th>
<italic>P</italic> Value</th>
<th>Haplotype</th>
<th>Frequency </th>
<th>
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="7">Two-marker sliding window haplotype analysis<sup><xref ref-type="table-fn" rid="table-fn21-1933719111417885">a</xref></sup>
</td>
</tr>
<tr>
<td>RS6269-RS4633</td>
<td>G-T</td>
<td>0.051</td>
<td>.65</td>
<td>G-T</td>
<td>0.37</td>
<td>.42</td>
</tr>
<tr>
<td>RS4633-RS4818</td>
<td>T-C</td>
<td>0.35</td>
<td>.75</td>
<td>T-C</td>
<td>0.30</td>
<td>&lt;.03</td>
</tr>
<tr>
<td>RS4818-RS4680</td>
<td>G-G</td>
<td>0.21</td>
<td>.79</td>
<td>C-A</td>
<td>0.29</td>
<td>&lt;.03</td>
</tr>
<tr>
<td colspan="7">Three-marker sliding window haplotype analysis</td>
</tr>
<tr>
<td>RS6269-RS4633-RS4818</td>
<td>A-T-C</td>
<td>0.30</td>
<td>.63</td>
<td>A-T-C</td>
<td>0.30</td>
<td>.10</td>
</tr>
<tr>
<td>RS4680-RS4818-RS4633</td>
<td>T-C-G</td>
<td>0.08</td>
<td>.23</td>
<td>C-C-G</td>
<td>0.44</td>
<td>&lt;.04</td>
</tr>
<tr>
<td colspan="7">Four-marker sliding window haplotype analysis</td>
</tr>
<tr>
<td>RS6269-RS4633-RS4818-RS4680</td>
<td>G-C-G-G</td>
<td>0.17</td>
<td>.41</td>
<td>A-T-C-A</td>
<td>0.28</td>
<td>.14</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn20-1933719111417885">
<p>Abbreviations: COMT, catechol-O-methyltransferase; SNP, single-nucleotide polymorphism.</p>
</fn>
<fn id="table-fn21-1933719111417885">
<p>
<sup>a</sup> PowerMarker and HaploView statistical softwares were used.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section16-1933719111417885">
<title>Linkage disequilibrium Characterization</title>
<p>Analysis showed that all 4 SNPs (rs4633, rs4680, rs4818, and rs6269) had <italic>D</italic>′ values of 1.0 and LOD &gt; 2 in Cau maternal (<xref ref-type="fig" rid="fig1-1933719111417885">Figure 1A</xref>; Panels a and b) and fetal samples (<xref ref-type="fig" rid="fig1-1933719111417885">Figure 1B</xref>; Panels a and b) in both the controls and cases (shown in red). African American (AA) maternal (<xref ref-type="fig" rid="fig1-1933719111417885">Figure 1A</xref>; Panel c) and fetal control (<xref ref-type="fig" rid="fig1-1933719111417885">Figure 1B</xref>; Panel c) samples showed a single haplotype block of 1.0 kb, encompassing rs4818 and rs4633 with 0.21 &lt; D′ &lt; 1 and LOD &gt; 2. In the AA cases, no haplotype block was observed and the D′ values (LOD &lt; 2) were low (maternal: <xref ref-type="fig" rid="fig1-1933719111417885">Figure 1A</xref>, Panel d; fetal: <xref ref-type="fig" rid="fig1-1933719111417885">Figure 1B</xref>, Panel d).</p>
</sec>
<sec id="section17-1933719111417885">
<title>Multifactor Dimensionality Reduction Analysis</title>
<p>Multilocus analysis performed in fetal DNA obtained from AA showed a significant association (<xref ref-type="table" rid="table8-1933719111417885">Table 8</xref>) between rs4818 and PTB (<italic>P</italic> = .01). The test showed a CV consistency of 10/10. However, we did not see any significant association between SNPs and PTB, either in AA maternal samples or in Cau maternal or fetal samples. </p>
<table-wrap id="table8-1933719111417885" position="float">
<label>Table 8.</label>
<caption>
<p>Multifactor Dimensionality Reduction Analysis in African American Fetal Samples</p>
</caption>
<graphic alternate-form-of="table8-1933719111417885" xlink:href="10.1177_1933719111417885-table8.tif"/>
<table>
<thead>
<tr>
<th>Model</th>
<th>Permutation <italic>P</italic> Value</th>
<th>CV Consistency</th>
</tr>
</thead>
<tbody>
<tr>
<td>RS4818</td>
<td>.01</td>
<td>10/10</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn22-1933719111417885">
<p>Abbreviation: CV, cross-validation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section18-1933719111417885">
<title>Discussion</title>
<p>To explain the high COMT activity in AA compared with Cau, we examined genetic variations in maternal and fetal DNA and their association with pregnancy outcome (case vs control). In this study, we demonstrated significant differences in the frequency of SNPs in both the maternal and the fetal DNA of cases and controls and the between-race differences in SNPs’ association with PTB. We investigated 4 SNPs (rs4633, rs4680, rs4818, and rs6269) in the COMT gene, based on the prior knowledge that these SNPs affect COMT enzyme activity.<sup>
<xref ref-type="bibr" rid="bibr32-1933719111417885">32</xref>
</sup> Because SNPs rs4633, rs4680, and rs4818 showed significant differences in allele and genotype frequencies in the fetal samples of cases and controls, we considered them for association analysis. Our results showed that SNP rs4818 in the fetal COMT gene is strongly associated with PTB in AA. However, in Cau, no such association was found with PTB in fetal or maternal DNA. This study demonstrated that a synonymous polymorphism, rs4818 in the COMT gene, is associated with PTB in AA fetal DNA at the allele and genotype levels. </p>
<p>Our study revealed that rs4818 in the COMT gene is associated with PTB in AA fetal DNA at the allele and genotype levels. Allele or genotype frequency differences in rs6269 and rs4633 were not significantly different in the maternal cases and controls. Therefore, we did not expect any association with PTB at the allele and genotype levels for the maternal data. The COMT<sup>
<xref ref-type="bibr" rid="bibr30-1933719111417885">30</xref>
</sup> is reported to create an 18-fold difference in expressed enzyme activity by modifying the secondary structure of messenger RNA (mRNA), which affects the mRNA stability.<sup>
<xref ref-type="bibr" rid="bibr32-1933719111417885">32</xref>
</sup> This is the first study in which mutation from C to G, a synonymous polymorphism (Leu/Leu) within the COMT gene that does not alter the structure of the COMT protein but impacts expression, is linked to a specific reproductive disorder, such as PTB. However, SNP rs4818 did not show any significant association with PTB in maternal DNA in either race or in Cau fetal DNA. </p>
<p>After the onset of spontaneous labor, there is an increase in the E<sub>2</sub>/P<sub>4</sub> ratio in amniotic fluid, probably because of alterations in the steroidogenic activity of the fetal membranes.<sup>
<xref ref-type="bibr" rid="bibr33-1933719111417885">33</xref>
</sup> The elevated COMT expression observed in the amnion of laboring participants and the inhibition of prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) by a specific COMT inhibitor in the amnion explants<sup>
<xref ref-type="bibr" rid="bibr8-1933719111417885">8</xref>
</sup> suggests that COMT secreted by fetal tissues increases the local estrogenic milieu and plays a role in labor and delivery. Results from our study suggest that SNP rs4818 in the fetal COMT gene is associated with PTB in AA and may explain the increased COMT activity in the AA cases. Data analysis revealed that the C allele at rs4818 in fetal COMT DNA showed a significant association with PTB. We also showed that this association was seen at genotype C/C and even at the haplotype (2- and 3-marker sliding window), suggesting that rs4818 in fetal COMT DNA is strongly associated with PTB. A study conducted by Roussos et al<sup>
<xref ref-type="bibr" rid="bibr34-1933719111417885">34</xref>
</sup> suggests that a synonymous polymorphism within the COMT gene rs4818 accounts for greater variation in COMT activity compared with the functional Val158Met polymorphism. Their study revealed that variants in rs4818 impart strong and differential effects on prefrontal cortex functions. Elevated COMT expression in the amnion of laboring women and PGE<sub>2 </sub>inhibition in amnion explant cultures treated with COMT-specific inhibitor in our laboratory suggest that COMT secreted by fetal membranes, particularly the amnion, regulates the onset of labor in term pregnancy.<sup>
<xref ref-type="bibr" rid="bibr8-1933719111417885">8</xref>
</sup> Thus, polymorphism in the COMT gene in fetal DNA can at least partially explain the higher incidence of PTB in AA.</p>
<p>The haplotype analysis documented the strong influence of rs4818 in AA fetal DNA and its association with PTB. Because the allele and genotype frequencies of rs6269 were not significantly different in the fetal DNA of the controls and cases, we did not expect any involvement of this SNP in PTB. The pairwise LD values for the 4 SNPs within the COMT gene were high in Cau, indicating a high degree of LD; these values were not different between the controls and cases for both maternal and fetal samples. As expected, in AA maternal and fetal control samples, the LD was not as dominant as it was in Cau. However, a single haplotype block of 1.0 kb, encompassing rs4818 and rs4633, was seen in the maternal and fetal controls, In AA maternal cases, LD values were lower than the controls and in the fetal cases where SNP rs4818 showed association with PTB no LD (white block) was evident. However, more data are required to confirm the findings. A CV consistency value of 10/10 and a <italic>P</italic> value of .01 after multilocus analysis (MDR) for rs4818 in fetal COMT DNA suggest the single strongest effect of rs4818, as no interactions were observed with any of the other SNPs studied. These results suggest that the SNP at rs4818 is strongly associated with PTB in AA.</p>
<p>In summary, our results provide evidence of the role of fetal COMT gene variant rs4818 in the incidence of PTB in AA. However, no such association was observed with either AA maternal samples or Cau maternal or fetal samples. Further investigations with a larger population are needed to determine whether COMT activity differs in early, mid, late, and recurrent PTBs. Additional studies are needed to understand the physiological role of COMT in the incidence of PTB. </p>
<fn-group>
<fn fn-type="conflict" id="fn1-1933719111417885">
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1933719111417885">
<p>The authors disclosed receipt of the following financial support for the, authorship, and/or publication of this article: Regional Centers for Minority Institution 5G12 RR003032-27.</p>
</fn>
</fn-group>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-1933719111417885">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamilton</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ventura</surname>
<given-names>SJ</given-names>
</name>
</person-group>. <article-title>Births: preliminary data for 2005</article-title>. <source>Natl Vital Stat Rep</source>. <year>2006</year>;<volume>55</volume>(<issue>11</issue>):<fpage>1</fpage>–<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr2-1933719111417885">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Sutton</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Ventura</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Menacker</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kirmeyer</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Births: final data for 2004</article-title>. <source>Natl Vital Stat Rep</source>. <year>2006</year>;<volume>55</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr3-1933719111417885">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Creasy</surname>
<given-names>RK</given-names>
</name>
</person-group>. <article-title>Preterm birth prevention: where are we?</article-title> <source>Am. J Obstet Gynecol</source>. <year>1993</year>;<volume>168</volume>(<issue>4</issue>):<fpage>1223</fpage>–<lpage>1230</lpage>.</citation>
</ref>
<ref id="bibr4-1933719111417885">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldenberg</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Cliver</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Mulvihill</surname>
<given-names>FX</given-names>
</name>
<etal/>
</person-group> <article-title>Medical, psychosocial, and behavioral risk factors do not explain the increased risk for low birth weight among black women</article-title>. <source>Am J Obstet Gynecol</source>. <year>1996</year>;<volume>175</volume>(<issue>5</issue>):<fpage>1317</fpage>–<lpage>1324</lpage>.</citation>
</ref>
<ref id="bibr5-1933719111417885">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Hendy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Salama</surname>
<given-names>SA</given-names>
</name>
</person-group>. <article-title>Catechol-<italic>O</italic>-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups</article-title>. <source>J Soc Gynecol Investig</source>. <year>2006</year>;<volume>13</volume>(<issue>2</issue>):<fpage>136</fpage>–<lpage>144</lpage>.</citation>
</ref>
<ref id="bibr6-1933719111417885">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>Y-S</given-names>
</name>
<name>
<surname>Gatley</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Fowler</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Volkow</surname>
<given-names>ND</given-names>
</name>
</person-group>. <article-title>Mapping catechol-O-methyltransferase in vivo: initial studies with [<sup>18</sup>F] Ro41-0960</article-title>. <source>Life Sci</source>. <year>1996</year>;<volume>58</volume>(<issue>3</issue>):<fpage>195</fpage>–<lpage>208</lpage>.</citation>
</ref>
<ref id="bibr7-1933719111417885">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wentz</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>SQ</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group> <article-title>Treatment with an inhibitor of catechol-O-methyltransferase activity reduces preterm birth and impedes cervical resistance to stretch in pregnant rats</article-title>. <source>Reproduction</source>. <year>2007</year>;<volume>134</volume>(<issue>6</issue>):<fpage>831</fpage>–<lpage>839</lpage>.</citation>
</ref>
<ref id="bibr8-1933719111417885">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harirah</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Thota</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wentz</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Zaman</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Al-Hendy</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Elevated expression of catechol-O-methyltransferase is associated with labor and increased prostaglandin E(2) production by human fetal membranes</article-title>. <source>Am J Obstet Gynecol</source>. <year>2009</year>;<volume>201</volume>(<issue>5</issue>):<fpage>496</fpage>.<comment>e1-496.e7</comment>
</citation>
</ref>
<ref id="bibr9-1933719111417885">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salminen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lundström</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tilgmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Savolainen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kalkkinen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ulmanen</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Molecular cloning and characterization of rat liver catechol-O-methyltransferase</article-title>. <source>Gene</source>. <year>1990</year>;<volume>93</volume>(<issue>2</issue>):<fpage>241</fpage>–<lpage>247</lpage>.</citation>
</ref>
<ref id="bibr10-1933719111417885">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tenhunen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ulmanen</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Production of rat soluble and membrane-bound catechol-O-methyltransferase forms from bifunctional mRNAs</article-title>. <source>Biochem J</source>. <year>1993</year>;<volume>296</volume>(<issue>pt 3</issue>):<fpage>595</fpage>–<lpage>600</lpage>.</citation>
</ref>
<ref id="bibr11-1933719111417885">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tenhunen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Salminen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jalanko</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ukkonen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ulmanen</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce messenger RNAs for soluble and membrane-bound forms of the enzyme</article-title>. <source>DNA Cell Biol</source>. <year>1993</year>;<volume>12</volume>(<issue>3</issue>):<fpage>253</fpage>–<lpage>263</lpage>.</citation>
</ref>
<ref id="bibr12-1933719111417885">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tenhunen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Salminen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lundström</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kiviluoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Savolainen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ulmanen</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Genomic organization of the human catechol <italic>O-</italic>methyltransferase gene and its expression from two distinct promoters. <italic>Eur J</italic>
</article-title> B<source>iochem. 1994;</source>22<year>3(3)</year>:<volume>104</volume>
<issue>9-1</issue>0<fpage>59</fpage>.</citation>
</ref>
<ref id="bibr13-1933719111417885">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guldberg</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Marsden</surname>
<given-names>CA</given-names>
</name>
</person-group>. <article-title>Catechol-O-methyltransferase: pharmacological aspects and physiological role</article-title>. <source>Pharmacol Rev</source>. <year>1975</year>;<volume>27</volume>(<issue>2</issue>):<fpage>135</fpage>–<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr14-1933719111417885">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacLusky</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Riskalla</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Krey</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Parvizi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Niftolin</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>Anovulation in female rats induced by neonatal administration of the catechol estrogens, 2-hydroxy-estradiol and 4-hydroxy-estradiol</article-title>. <source>Neuroendocrinology</source>. <year>1983</year>;<volume>37</volume>(<issue>5</issue>):<fpage>321</fpage>–<lpage>327</lpage>.</citation>
</ref>
<ref id="bibr15-1933719111417885">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Aswegen</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Purdy</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Wittliff</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>Binding of 2-hydroxyestradiol and 4-hydroxyestridiol to estrogen receptor human breast cancers</article-title>. <source>J Steroid Biochem</source>. <year>1989</year>;<volume>32</volume>(<issue>4</issue>):<fpage>485</fpage>–<lpage>492</lpage>.</citation>
</ref>
<ref id="bibr16-1933719111417885">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feigelson</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>BE</given-names>
</name>
</person-group>. <article-title>Estrogens and breast cancer</article-title>. <source>Carcinogenesis</source>. <year>1996</year>;<volume>17</volume>(<issue>11</issue>):<fpage>2279</fpage>–<lpage>2284</lpage>.</citation>
</ref>
<ref id="bibr17-1933719111417885">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kraychy</surname>
<given-names>S</given-names>
</name>
</person-group>, <article-title>Gallagher TF. 2-Methoxyestrone, a new metabolite of estradiol-17 β in man</article-title>. <source>J Biol Chem</source>. <year>1957</year>;<volume>229</volume>(<issue>1</issue>):<fpage>519</fpage>–<lpage>526</lpage>.</citation>
</ref>
<ref id="bibr18-1933719111417885">
<label>18</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Dunn</surname>
<given-names>JF</given-names>
</name>
</person-group>. <article-title>Transport of estrogens in human plasma</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Merriem</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Lipsett</surname>
<given-names>MB</given-names>
</name>
</person-group>, eds. <source>Catechol Estrogens</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Raven Press</publisher-name>; <year>1983</year>:<fpage>167</fpage>–<lpage>176</lpage>.</citation>
</ref>
<ref id="bibr19-1933719111417885">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klauber</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Parangi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Flynn</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hamel</surname>
<given-names>E</given-names>
</name>
<name>
<surname>D’Amato</surname>
<given-names>RJ</given-names>
</name>
</person-group>. <article-title>Inhibition of angiogenesis and breast cancer in mice by microtubule inhibitors 2-methoxyestradiol and taxol</article-title>. <source>Cancer Res</source>. <year>1997</year>;<volume>57</volume>:<fpage>81</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr20-1933719111417885">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanasaki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Palmsten</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sugimoto</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group> <article-title>Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia</article-title>. <source>Nature</source>. <year>2008</year>;<volume>453</volume>(<issue>7198</issue>):<fpage>1117</fpage>–<lpage>1121</lpage>. </citation>
</ref>
<ref id="bibr21-1933719111417885">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thapar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Langley</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fowler</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> <article-title>Catechol-O-methyltransferase gene variant and birth weight predict early onset antisocial behavior in children with attention deficit/hyperactivity disorder</article-title>. <source>Arch Gen Psychiatry</source>. <year>2005</year>;<volume>62</volume>(<issue>11</issue>):<fpage>1275</fpage>–<lpage>1278</lpage>.</citation>
</ref>
<ref id="bibr22-1933719111417885">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Velez</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Thorsen</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>Ethnic differences in key candidate genes for spontaneous preterm birth: TNF-alpha and its receptors</article-title>. <source>Hum Hered</source>. <year>2006</year>;<volume>62</volume>(<issue>2</issue>):<fpage>107</fpage>–<lpage>118</lpage>.</citation>
</ref>
<ref id="bibr23-1933719111417885">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaykin</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Westfall</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>SS</given-names>
</name>
<etal/>
</person-group> <article-title>Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals</article-title>. <source>Hum Hered</source>. <year>2002</year>;<volume>53</volume>(<issue>2</issue>):<fpage>79</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr24-1933719111417885">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raymond</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rousset</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>An exact test for population differentiation</article-title>. <source>Evolution</source>. <year>1995</year>;<volume>49</volume>(<issue>6</issue>):<fpage>1280</fpage>–<lpage>1283</lpage>.</citation>
</ref>
<ref id="bibr25-1933719111417885">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritchie</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>JH</given-names>
</name>
</person-group>. <article-title>Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity</article-title>. <source>Genet Epidemiol</source>. <year>2003</year>;<volume>24</volume>(<issue>2</issue>):<fpage>150</fpage>–<lpage>157</lpage>.</citation>
</ref>
<ref id="bibr26-1933719111417885">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gabriel</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Schaffner</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group> The structure of haplotype blocks in the human genome. <source>Science</source>. <year>2002</year>;<volume>296</volume>(<issue>5576</issue>):<fpage>2225</fpage>–<lpage>2229</lpage>.</citation>
</ref>
<ref id="bibr27-1933719111417885">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Provost</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>Learning when training data are costly: the effect of class distribution on tree induction</article-title>. <source>J Artif Intell Res</source>. <year>2003</year>;<volume>19</volume>(<issue>1</issue>):<fpage>315</fpage>–<lpage>354</lpage>.</citation>
</ref>
<ref id="bibr28-1933719111417885">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Japkowicz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Stephen</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>The class imbalance problem: a systematic study</article-title>. <source>Intell Data Anal</source>. <year>2002</year>;<volume>6</volume>(<issue>5</issue>):<fpage>429</fpage>–<lpage>449</lpage>.</citation>
</ref>
<ref id="bibr29-1933719111417885">
<label>29</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Fleiss</surname>
<given-names>JL</given-names>
</name>
</person-group>. <source>Statistical Methods for Rates and Proportions</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Wiley</publisher-name>; <year>1981</year>.</citation>
</ref>
<ref id="bibr30-1933719111417885">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diatchenko</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Slade</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Nackley</surname>
<given-names>AG</given-names>
</name>
<etal/>
</person-group> <article-title>Genetic basis for individual variations in pain perception and the development of a chronic pain condition</article-title>. <source>Hum Mol Genet</source>. <year>2005</year>;<volume>14</volume>
<issue>(</issue>
<issue>1</issue>
<issue>)</issue>:<fpage>135</fpage>–<lpage>143</lpage>. </citation>
</ref>
<ref id="bibr31-1933719111417885">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Muse</surname>
<given-names>SV</given-names>
</name>
</person-group>. <article-title>PowerMarker: an integrated analysis environment for genetic marker analysis</article-title>. <source>Bioinformatics</source>. <year>2005</year>;<volume>21</volume>(<issue>9</issue>):<fpage>2128</fpage>–<lpage>2129</lpage>.</citation>
</ref>
<ref id="bibr32-1933719111417885">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nackley</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Shabalina</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Tchivileva</surname>
<given-names>IE</given-names>
</name>
<etal/>
</person-group> <article-title>Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure</article-title>. <source>Science</source>. <year>2006</year>;<volume>314</volume>(<issue>5807</issue>):<fpage>1930</fpage>–<lpage>1933</lpage>.</citation>
</ref>
<ref id="bibr33-1933719111417885">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keelan</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>The molecular mechanisms of term and preterm labor: recent progress and clinical implications</article-title>. <source>Clin Obstet <italic>Gynecol</italic>
</source>. <year>1997</year>;<volume>40</volume>(<issue>3</issue>):<fpage>460</fpage>–<lpage>478</lpage>.</citation>
</ref>
<ref id="bibr34-1933719111417885">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roussos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Giakoumaki</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Pavlakis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bitsios</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Planning, decision making and the COMT rs4818 polymorphism in healthy males</article-title>. Neuropsychologia. <year>2008</year>;<volume>46</volume>(<issue>2</issue>):<fpage>757</fpage>–<lpage>763</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>